Status: current, Defined. Date: 30-Nov 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4270821000168117 | Kanjinti (trastuzumab 150 mg) powder for injection, 1 x 150 mg vial (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4270831000168119 | Kanjinti 150 mg powder for injection, 1 vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Kanjinti 150 mg powder for injection, 1 vial | Is a | trastuzumab 150 mg injection, 1 vial | true | Inferred relationship | Some | ||
| Kanjinti 150 mg powder for injection, 1 vial | Is a | trade product pack | true | Inferred relationship | Some | ||
| Kanjinti 150 mg powder for injection, 1 vial | has TP | Kanjinti | true | Inferred relationship | Some | ||
| Kanjinti 150 mg powder for injection, 1 vial | has TPUU | Kanjinti 150 mg powder for injection, 150 mg vial | true | Inferred relationship | Some | 1892751727 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Kanjinti 150 mg powder for injection, 1 vial | Is a | True | Kanjinti 150 mg powder for injection, 1 vial | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR